Status:
WITHDRAWN
Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Spinal Cord Injuries
Neuralgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Around 80% of people with spinal cord injury (SCI) develop chronic neuropathic pain (CNP). This is a debilitating condition with major negative impacts on people's quality of life. Many treatment opti...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- presence of chronic neuropathic pain at or below SCI level for at least 6 months following trauma or disease of the spinal cord.
- cervical lesion.
- CNP in the upper extremity.
- pain intensity of at least 4 out of 10 in the numerical rating scale (NRS) in the NPS both screening (baseline) and randomization (pre-evaluation).both screening (baseline) and randomization (pre-evaluation).
- stable pharmacological treatment for at least 2 weeks prior to the study and throughout the trial.
- complete or incomplete lesion.
- Exclusion criteria:
Exclusion
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05226676
Start Date
August 1 2023
End Date
December 1 2023
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abilities Research Center
New York, New York, United States, 10029